Xtant Medical Reports Third Quarter 2026 Financial Results with Revenue and EPS Miss

Xtant Medical (XTNT) reported third-quarter financial results that fell short of market expectations. The company posted a GAAP earnings per share (EPS) loss of $0.03, missing estimates by $0.01. Total revenue for the quarter reached $24.3 million, representing a 26.9% decline year-over-year and falling $1.18 million below consensus forecasts. The company also reported a significant downturn in profitability metrics. Adjusted EBITDA swung to a loss of $1.5 million for the third quarter of 2026, a sharp reversal from the adjusted EBITDA profit of $4.5 million recorded in the prior year period.

By https://seekingalpha.com/user/52365730/bio · Seeking Alpha ·

Xtant Medical Reports Third Quarter 2026 Financial Results with Revenue and EPS Miss

Tickers: $XTNT

Topics: adjusted EBITDA earnings miss GAAP EPS revenue decline

Read the full article at Seeking Alpha

Part of the story Elah Holdings, Inc. Releases Third Quarter 2026 Financial Statements (8 articles)

More World news